Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress Post author:Sam Post published:June 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like $710M Gamble Fails as Celgene Terminates Two Phase III Trials October 19, 2017 <b>Flowjo, LLC</b> Launches Cloud Platform For Multi-Omics Experiments May 22, 2017 Interim CEO Named Permanent Leader at Tango Therapeutics September 24, 2017